Clinical Outcomes After Anterior Cruciate Ligament Injury: Panther Symposium ACL Injury Clinical Outcomes Consensus Group

Abstract

A stringent outcome assessment is a key aspect of establishing evidence-based clinical guidelines for anterior cruciate ligament (ACL) injury treatment. To establish a standardized assessment of clinical outcome after ACL treatment, a consensus meeting including a multidisciplinary group of ACL experts was held at the ACL Consensus Meeting Panther Symposium, Pittsburgh, Pennsylvania, USA, in June 2019. The aim was to establish a consensus on what data should be reported when conducting an ACL outcome study, what specific outcome measurements should be used, and at what follow-up time those outcomes should be assessed. The group reached consensus on 9 statements by using a modified Delphi method. In general, outcomes after ACL treatment can be divided into 4 robust categories: early adverse events, patient-reported outcomes (PROs), ACL graft failure/recurrent ligament disruption, and clinical measures of knee function and structure. A comprehensive assessment after ACL treatment should aim to provide a complete overview of the treatment result, optimally including the various aspects of outcome categories. For most research questions, a minimum follow-up of 2 years with an optimal follow-up rate of 80% is necessary to achieve a comprehensive assessment. This should include clinical examination, any sustained reinjuries, validated knee-specific PROs, and health-related quality of life questionnaires. In the midterm to long-term follow-up, the presence of osteoarthritis should be evaluated. This consensus paper provides practical guidelines for how the aforementioned entities of outcomes should be reported and suggests the preferred tools for a reliable and valid assessment of outcome after ACL treatment.

Does sex affect second ACL injury risk? A systematic review with meta-analysis

“…The risk of bias concerns and noted high heterogeneity (I 2 >50%) seen in most analyses dictate that studies examining second ACL injury outcomes should ensure they adhere to established guidelines (eg, STROBE or CONSORT) in the design and execution of the final manuscript to ensure potential sources of bias are mitigated. [84][85][86] Of note, the Panther Symposium and Consensus Statements have been recently published and should provide an in-depth guide to…”

“…help standardise the research on ACL reconstruction outcomes, including return-to-sport outcomes and second ACL injury definitions. 85…”

Quadriceps and hamstring tendon autografts in ACL reconstruction yield comparably good results in a prospective, randomized controlled trial

“…Therefore, high-level data comparing outcomes of quadriceps and hamstring tendon grafts for ACL reconstruction is sparse [35].…”

A Systematic Review of Randomized Controlled Trials in Anterior Cruciate Ligament Reconstruction: Standard Techniques Are Comparable (299 Trials With 25,816 Patients)

“…In recognition of this challenge, the Panther Symposium ACL Injury Clinical Outcomes Consensus Group has recently published their consensus paper providing practical guidelines on preferred tools for reliable and valid assessment of outcomes after ACL treatment. 7 High-quality randomized controlled trials (RCTs) provide strong evidence for the efficacy of health care interventions and help to inform evidence-based practice. 8,9 This is especially true of RCTs, which show a statistically significant difference in the results of 2 treatments, or the absence of a significant difference but a narrow confidence interval indicating a positive effect of a treatment.…”